502 related articles for article (PubMed ID: 15811136)
1. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism.
de Boer H; Verschoor L; Ruinemans-Koerts J; Jansen M
Diabetes Obes Metab; 2005 May; 7(3):211-5. PubMed ID: 15811136
[TBL] [Abstract][Full Text] [Related]
2. Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism.
Loves S; Ruinemans-Koerts J; de Boer H
Eur J Endocrinol; 2008 May; 158(5):741-7. PubMed ID: 18426834
[TBL] [Abstract][Full Text] [Related]
3. Somatic and psychological effects of low-dose aromatase inhibition in men with obesity-related hypogonadotropic hypotestosteronemia.
Loves S; de Jong J; van Sorge A; Telting D; Tack CJ; Hermus A; Westerterp K; de Boer H
Eur J Endocrinol; 2013 Nov; 169(5):705-14. PubMed ID: 23949882
[TBL] [Abstract][Full Text] [Related]
4. Aromatase inhibition, testosterone, and seizures.
Harden C; MacLusky NJ
Epilepsy Behav; 2004 Apr; 5(2):260-3. PubMed ID: 15123030
[TBL] [Abstract][Full Text] [Related]
5. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
Dougherty RH; Rohrer JL; Hayden D; Rubin SD; Leder BZ
Clin Endocrinol (Oxf); 2005 Feb; 62(2):228-35. PubMed ID: 15670201
[TBL] [Abstract][Full Text] [Related]
6. A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism.
Herzog AG; Farina EL; Drislane FW; Schomer DL; Smithson SD; Fowler KM; Dworetzky BA; Bromfield EB
Epilepsy Behav; 2010 Feb; 17(2):264-71. PubMed ID: 20096638
[TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation.
Holbrook JM; Cohen PG
South Med J; 2003 Jun; 96(6):544-7. PubMed ID: 12938779
[TBL] [Abstract][Full Text] [Related]
8. Selective aromatase inhibition for patients with androgen-independent prostate carcinoma.
Smith MR; Kaufman D; George D; Oh WK; Kazanis M; Manola J; Kantoff PW
Cancer; 2002 Nov; 95(9):1864-8. PubMed ID: 12404279
[TBL] [Abstract][Full Text] [Related]
9. LH and non-SHBG testosterone and estradiol levels during testosterone replacement of hypogonadal men: further evidence that steroid negative feedback increases as men grow older.
Winters SJ; Wang C;
J Androl; 2010; 31(3):281-7. PubMed ID: 19959827
[TBL] [Abstract][Full Text] [Related]
10. Letrozole versus testosterone. a single-center pilot study of HIV-infected men who have sex with men on highly active anti-retroviral therapy (HAART) with hypoactive sexual desire disorder and raised estradiol levels.
Richardson D; Goldmeier D; Frize G; Lamba H; De Souza C; Kocsis A; Scullard G
J Sex Med; 2007 Mar; 4(2):502-8. PubMed ID: 17367446
[TBL] [Abstract][Full Text] [Related]
11. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome.
Niskanen L; Laaksonen DE; Punnonen K; Mustajoki P; Kaukua J; Rissanen A
Diabetes Obes Metab; 2004 May; 6(3):208-15. PubMed ID: 15056129
[TBL] [Abstract][Full Text] [Related]
12. Partial reversal of the hypogonadotropic hypogonadism of obese men by administration of corticosuppressive doses of dexamethasone.
Zumoff B; Strain GW; Miller LK; Rosner W; Levit CD; Miller EH; Rosenfeld RS
Int J Obes; 1988; 12(6):525-31. PubMed ID: 3148562
[TBL] [Abstract][Full Text] [Related]
13. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
Lanfranco F; Zitzmann M; Simoni M; Nieschlag E
Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
[TBL] [Abstract][Full Text] [Related]
14. Aromatase activity after a short-course of letrozole administration in adult men at sea level and at high altitude (with or without excessive erythrocytosis).
Gonzales GF; Tapia V; Gasco M; Gonzales-Castañeda C
Horm Metab Res; 2012 Feb; 44(2):140-5. PubMed ID: 22274717
[TBL] [Abstract][Full Text] [Related]
15. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial.
Davis SR; Goldstat R; Papalia MA; Shah S; Kulkarni J; Donath S; Bell RJ
Menopause; 2006; 13(1):37-45. PubMed ID: 16607097
[TBL] [Abstract][Full Text] [Related]
16. Testosterone and gonadotropin levels in men with dementia.
Hogervorst E; Combrinck M; Smith AD
Neuro Endocrinol Lett; 2003; 24(3-4):203-8. PubMed ID: 14523358
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.
Kapoor D; Aldred H; Clark S; Channer KS; Jones TH
Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552
[TBL] [Abstract][Full Text] [Related]
18. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK
Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152
[TBL] [Abstract][Full Text] [Related]
19. Evidence for hypogonadism in massively obese males due to decreased free testosterone.
Kley HK; Deselaers T; Peerenboom H
Horm Metab Res; 1981 Nov; 13(11):639-41. PubMed ID: 7198085
[TBL] [Abstract][Full Text] [Related]
20. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
Moisey R; Swinburne J; Orme S
Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
